======= FOXK2 ======= == Gene Information == * **Official Symbol**: FOXK2 * **Official Name**: forkhead box K2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3607|3607]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q01167|Q01167]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FOXK2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FOXK2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/147685|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional regulator that recognizes the core sequence 5'-TAAACA-3'. Binds to NFAT-like motifs (purine-rich) in the IL2 promoter (PubMed:1339390). Positively regulates WNT/beta- catenin signaling by translocating DVL proteins into the nucleus (PubMed:25805136). Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements (PubMed:1909027). {ECO:0000269|PubMed:1339390, ECO:0000269|PubMed:1909027, ECO:0000269|PubMed:25805136}. |Fork head| |FHA| |regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter| |regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter| |NADH regeneration| |glucose catabolic process to pyruvate| |canonical glycolysis| |glycolytic process through glucose-6-phosphate| |glycolytic process through fructose-6-phosphate| |glucose catabolic process| |NADH metabolic process| |glycolytic process| |ATP generation from ADP| |regulation of gluconeogenesis| |NAD metabolic process| |ADP metabolic process| |hexose catabolic process| |nucleoside diphosphate phosphorylation| |purine ribonucleoside diphosphate metabolic process| |nucleotide phosphorylation| |purine nucleoside diphosphate metabolic process| |monosaccharide catabolic process| |ribonucleoside diphosphate metabolic process| |pyruvate metabolic process| |transcription regulatory region sequence-specific DNA binding| |nucleoside diphosphate metabolic process| |negative regulation of autophagy| |cellular glucose homeostasis| |regulation of carbohydrate biosynthetic process| |glucose metabolic process| |regulation of glucose metabolic process| |carbohydrate catabolic process| |regulation of cellular carbohydrate metabolic process| |hexose metabolic process| |glucose homeostasis| |carbohydrate homeostasis| |response to starvation| |monosaccharide metabolic process| |ATP metabolic process| |regulation of carbohydrate metabolic process| |magnesium ion binding| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |negative regulation of cellular catabolic process| |protein deubiquitination| |protein modification by small protein removal| |negative regulation of catabolic process| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |regulation of autophagy| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |sequence-specific DNA binding| |generation of precursor metabolites and energy| |regulation of small molecule metabolic process| |small molecule catabolic process| |nucleotide metabolic process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |nucleoside phosphate metabolic process| |carbohydrate metabolic process| |response to nutrient levels| |RNA polymerase II proximal promoter sequence-specific DNA binding| |monocarboxylic acid metabolic process| |response to extracellular stimulus| |nucleobase-containing small molecule metabolic process| |DNA-binding transcription factor activity| |cellular chemical homeostasis| |regulation of cellular catabolic process| |negative regulation of transcription by RNA polymerase II| |organophosphate metabolic process| |cellular homeostasis| |carboxylic acid metabolic process| |oxidation-reduction process| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |chemical homeostasis| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |proteolysis| |phosphorylation| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |small molecule metabolic process| |organic substance catabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-2.19| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-2.07| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.01| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-1.97| |[[:results:exp359|FK-506 30μM R07 exp359]]|-1.96| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|-1.95| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.94| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.75| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.406| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4247 * **Expression level (log2 read counts)**: 6.87 {{:chemogenomics:nalm6 dist.png?nolink |}}